Sutro Biopharma, Inc. (S09.F)
Frankfurt - Frankfurt Delayed Price. Currency in EUR
Add to watchlist
As of 03:29PM CEST. Market open.
Currency in EUR
Valuation Measures4
| Market Cap (intraday) | 257.56M |
| Enterprise Value | -100.07M |
| Trailing P/E | 82.31 |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 1.36 |
| Price/Book (mrq) | 1.88 |
| Enterprise Value/Revenue | 0.36 |
| Enterprise Value/EBITDA | N/A |
Trading Information
Stock Price History
| Beta (5Y Monthly) | 1.17 |
| 52-Week Change 3 | 5.41% |
| S&P500 52-Week Change 3 | 34.08% |
| 52 Week High 3 | 5.4500 |
| 52 Week Low 3 | 1.9100 |
| 50-Day Moving Average 3 | 3.5932 |
| 200-Day Moving Average 3 | 3.7170 |
Share Statistics
| Avg Vol (3 month) 3 | 40 |
| Avg Vol (10 day) 3 | N/A |
| Shares Outstanding 5 | 81.96M |
| Implied Shares Outstanding 6 | 83.35M |
| Float 8 | 64.53M |
| % Held by Insiders 1 | 0.96% |
| % Held by Institutions 1 | 78.18% |
| Shares Short 4 | N/A |
| Short Ratio 4 | N/A |
| Short % of Float 4 | N/A |
| Short % of Shares Outstanding 4 | N/A |
| Shares Short (prior month ) 4 | N/A |
Dividends & Splits
| Forward Annual Dividend Rate 4 | N/A |
| Forward Annual Dividend Yield 4 | N/A |
| Trailing Annual Dividend Rate 3 | 0.00 |
| Trailing Annual Dividend Yield 3 | 0.00% |
| 5 Year Average Dividend Yield 4 | N/A |
| Payout Ratio 4 | 0.00% |
| Dividend Date 3 | N/A |
| Ex-Dividend Date 4 | N/A |
| Last Split Factor 2 | N/A |
| Last Split Date 3 | N/A |
Financial Highlights
Currency in USD.Fiscal Year
| Fiscal Year Ends | Dec 31, 2023 |
| Most Recent Quarter (mrq) | Jun 30, 2024 |
Profitability
| Profit Margin | -73.48% |
| Operating Margin (ttm) | -189.39% |
Management Effectiveness
| Return on Assets (ttm) | -13.91% |
| Return on Equity (ttm) | -81.10% |
Income Statement
| Revenue (ttm) | 169.36M |
| Revenue Per Share (ttm) | 2.56 |
| Quarterly Revenue Growth (yoy) | 146.90% |
| Gross Profit (ttm) | N/A |
| EBITDA | -99.12M |
| Net Income Avi to Common (ttm) | -124.45M |
| Diluted EPS (ttm) | -1.5900 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 425.99M |
| Total Cash Per Share (mrq) | 5.2 |
| Total Debt (mrq) | 26.53M |
| Total Debt/Equity (mrq) | 17.43% |
| Current Ratio (mrq) | 3.41 |
| Book Value Per Share (mrq) | 1.86 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -74.72M |
| Levered Free Cash Flow (ttm) | 20.67M |
© 2024 Yahoo. All rights reserved.